Loading organizations...
Loading organizations...
Developer of next-generation gene editing tools for disease cures.
Integra Therapeutics has raised $30.7M across 4 funding rounds.
Integra Therapeutics has raised $30.7M in total across 4 funding rounds.
Integra Therapeutics has raised $30.7M in total across 4 funding rounds.
Integra Therapeutics's investors include Advent France Biotechnology, CDTI, Columbus Venture Partners, Svetoslava Georgieva, Invivo Capital, Takeda Ventures, European Innovation Council, Damià Tormo, Lluis Pareras, Miles Gerson, Matthieu Coutet.
Integra Therapeutics has raised $30.7M across 4 funding rounds. Most recently, it raised $12.5M Pre-Series A in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 8, 2025 | $12.5M Pre-Series A | Advent France Biotechnology, CDTI, Columbus Venture Partners, Svetoslava Georgieva, Invivo Capital, Takeda Ventures | |
| Jul 17, 2024 | $11.4M Grant / Other Equity | European Innovation Council | |
| Mar 30, 2022 | $1.7M Seed | Damià Tormo | |
| Dec 2, 2021 | $5.1M Seed | Lluis Pareras, Miles Gerson, Matthieu Coutet |